528 related articles for article (PubMed ID: 27519616)
1. Male sexual dysfunction after rectal cancer surgery: Results of a randomized trial comparing mesorectal excision with and without lateral lymph node dissection for patients with lower rectal cancer: Japan Clinical Oncology Group Study JCOG0212.
Saito S; Fujita S; Mizusawa J; Kanemitsu Y; Saito N; Kinugasa Y; Akazai Y; Ota M; Ohue M; Komori K; Shiozawa M; Yamaguchi T; Akasu T; Moriya Y;
Eur J Surg Oncol; 2016 Dec; 42(12):1851-1858. PubMed ID: 27519616
[TBL] [Abstract][Full Text] [Related]
2. Postoperative morbidity and mortality after mesorectal excision with and without lateral lymph node dissection for clinical stage II or stage III lower rectal cancer (JCOG0212): results from a multicentre, randomised controlled, non-inferiority trial.
Fujita S; Akasu T; Mizusawa J; Saito N; Kinugasa Y; Kanemitsu Y; Ohue M; Fujii S; Shiozawa M; Yamaguchi T; Moriya Y;
Lancet Oncol; 2012 Jun; 13(6):616-21. PubMed ID: 22591948
[TBL] [Abstract][Full Text] [Related]
3. Urinary dysfunction after rectal cancer surgery: Results from a randomized trial comparing mesorectal excision with and without lateral lymph node dissection for clinical stage II or III lower rectal cancer (Japan Clinical Oncology Group Study, JCOG0212).
Ito M; Kobayashi A; Fujita S; Mizusawa J; Kanemitsu Y; Kinugasa Y; Komori K; Ohue M; Ota M; Akazai Y; Shiozawa M; Yamaguchi T; Akasu T; Moriya Y;
Eur J Surg Oncol; 2018 Apr; 44(4):463-468. PubMed ID: 29428473
[TBL] [Abstract][Full Text] [Related]
4. Mesorectal Excision With or Without Lateral Lymph Node Dissection for Clinical Stage II/III Lower Rectal Cancer (JCOG0212): A Multicenter, Randomized Controlled, Noninferiority Trial.
Fujita S; Mizusawa J; Kanemitsu Y; Ito M; Kinugasa Y; Komori K; Ohue M; Ota M; Akazai Y; Shiozawa M; Yamaguchi T; Bandou H; Katsumata K; Murata K; Akagi Y; Takiguchi N; Saida Y; Nakamura K; Fukuda H; Akasu T; Moriya Y;
Ann Surg; 2017 Aug; 266(2):201-207. PubMed ID: 28288057
[TBL] [Abstract][Full Text] [Related]
5. Long-term follow-up of the randomized trial of mesorectal excision with or without lateral lymph node dissection in rectal cancer (JCOG0212).
Tsukamoto S; Fujita S; Ota M; Mizusawa J; Shida D; Kanemitsu Y; Ito M; Shiomi A; Komori K; Ohue M; Akazai Y; Shiozawa M; Yamaguchi T; Bando H; Tsuchida A; Okamura S; Akagi Y; Takiguchi N; Saida Y; Akasu T; Moriya Y;
Br J Surg; 2020 Apr; 107(5):586-594. PubMed ID: 32162301
[TBL] [Abstract][Full Text] [Related]
6. Potential sexual function improvement by using transanal mesorectal approach for laparoscopic low rectal cancer excision.
Pontallier A; Denost Q; Van Geluwe B; Adam JP; Celerier B; Rullier E
Surg Endosc; 2016 Nov; 30(11):4924-4933. PubMed ID: 26944728
[TBL] [Abstract][Full Text] [Related]
7. Postoperative morbidity and mortality after mesorectal excision with laparoscopic versus conventional open lateral lymph node dissection for advanced rectal cancer: A meta-analysis.
Du R; Zhou J; Li D; Zhang Q; Liu J; Ma C; Wang L; Wang D
Asian J Surg; 2021 Jan; 44(1):26-35. PubMed ID: 32798083
[TBL] [Abstract][Full Text] [Related]
8. Predictive factors of pathological lateral pelvic lymph node metastasis in patients without clinical lateral pelvic lymph node metastasis (clinical stage II/III): The analysis of data from the clinical trial (JCOG0212).
Komori K; Fujita S; Mizusawa J; Kanemitsu Y; Ito M; Shiomi A; Ohue M; Ota M; Akazai Y; Shiozawa M; Yamaguchi T; Bandou H; Katsumata K; Kinugasa Y; Takii Y; Akasu T; Moriya Y;
Eur J Surg Oncol; 2019 Mar; 45(3):336-340. PubMed ID: 30477950
[TBL] [Abstract][Full Text] [Related]
9. [Transanal lateral lymph node dissection surgery for 5 cases of mid-low rectal cancer].
Zeng ZW; Zhang XW; Chen JJ; Huang L; Luo SL; Kang L
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Aug; 22(8):781-785. PubMed ID: 31422618
[No Abstract] [Full Text] [Related]
10. [Short-term efficacy of robotic-assisted total mesorectal excision with and without lateral lymph node dissection for mid-low advanced rectal cancer: a propensity score matching analysis].
Shi FY; Zhang L; Qin Q; Jin X; Hu CH; Yu TY; Ma L; Wang GH; Wu H; Xia P; Sun XJ; She JJ
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Apr; 23(4):370-376. PubMed ID: 32306605
[No Abstract] [Full Text] [Related]
11. [Comparison on efficacy between fascia-oriented versus vascular-oriented lateral lymph node dissection in patients with rectal cancer].
Wang ZJ; Liu Z; Liang JW; Zhang MG; Mei SW; Shen HY; Chen JN; Li J; Zhao FQ; Wei FZ; Xiao TX; Liu Q
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Jul; 24(7):611-618. PubMed ID: 34289546
[No Abstract] [Full Text] [Related]
12. Is it time to rethink the rule of total mesorectal excision? A prospective radiological and pathological study in 49 consecutive patients with mid-rectal cancer.
Guedj N; Zappa M; Maggiori L; Bertin C; Hennequin C; Panis Y
Colorectal Dis; 2016 Sep; 18(9):O314-21. PubMed ID: 27381492
[TBL] [Abstract][Full Text] [Related]
13. The efficacy and safety of lateral lymph node dissection for patients with rectal cancer: A systematic review and meta-analysis.
Ma P; Yuan Y; Yan P; Chen G; Ma S; Niu X; Xu M; Yang K; Cai H
Asian J Surg; 2020 Sep; 43(9):891-901. PubMed ID: 31926817
[TBL] [Abstract][Full Text] [Related]
14. Lateral pelvic lymph node dissection after neoadjuvant chemo-radiation for preoperative enlarged lateral nodes in advanced low rectal cancer: study protocol for a randomized controlled trial.
Wei M; Wu Q; Fan C; Li Y; Chen X; Zhou Z; Han J; Wang Z
Trials; 2016 Nov; 17(1):561. PubMed ID: 27884204
[TBL] [Abstract][Full Text] [Related]
15. Potential impact of lateral lymph node dissection (LLND) for low rectal cancer on prognoses and local control: A comparison of 2 high-volume centers in Japan that employ different policies concerning LLND.
Kanemitsu Y; Komori K; Shida D; Ochiai H; Tsukamoto S; Kinoshita T; Moriya Y
Surgery; 2017 Aug; 162(2):303-314. PubMed ID: 28366499
[TBL] [Abstract][Full Text] [Related]
16. Laparoscopic pelvic autonomic nerve-preserving surgery for patients with lower rectal cancer after chemoradiation therapy.
Liang JT; Lai HS; Lee PH
Ann Surg Oncol; 2007 Apr; 14(4):1285-7. PubMed ID: 17235719
[TBL] [Abstract][Full Text] [Related]
17. Exploratory analysis of lateral pelvic sentinel lymph node status for optimal management of laparoscopic lateral lymph node dissection in advanced lower rectal cancer without suspected lateral lymph node metastasis.
Yasui M; Ohue M; Noura S; Miyoshi N; Takahashi Y; Matsuda C; Nishimura J; Haraguchi N; Ushigome H; Nakai N; Fujino S; Sugimura K; Wada H; Takahashi H; Omori T; Miyata H
BMC Cancer; 2021 Aug; 21(1):911. PubMed ID: 34380428
[TBL] [Abstract][Full Text] [Related]
18. Impact of autonomic nerve preservation and lateral node dissection on male urogenital function after total mesorectal excision for lower rectal cancer.
Kyo K; Sameshima S; Takahashi M; Furugori T; Sawada T
World J Surg; 2006 Jun; 30(6):1014-9. PubMed ID: 16736330
[TBL] [Abstract][Full Text] [Related]
19. Transanal Total Mesorectal Excision vs Laparoscopic Total Mesorectal Excision in the Treatment of Low and Middle Rectal Cancer: A Propensity Score Matching Analysis.
Persiani R; Biondi A; Pennestrì F; Fico V; De Simone V; Tirelli F; Santullo F; D'Ugo D
Dis Colon Rectum; 2018 Jul; 61(7):809-816. PubMed ID: 29771810
[TBL] [Abstract][Full Text] [Related]
20. Laparoscopic lateral pelvic lymph node dissection for lower rectal cancer treated with preoperative chemoradiotherapy.
Matsuda T; Hasegawa H; Yamashita K; Tanaka T; Yamamoto M; Kanaji S; Oshikiri T; Nakamura T; Sumi Y; Suzuki S; Kakeji Y
Surg Endosc; 2020 Mar; 34(3):1425-1431. PubMed ID: 31628619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
